CY1692A - Use of ketone derivatives in the treatments of cognitive disorders - Google Patents
Use of ketone derivatives in the treatments of cognitive disordersInfo
- Publication number
- CY1692A CY1692A CY169294A CY169294A CY1692A CY 1692 A CY1692 A CY 1692A CY 169294 A CY169294 A CY 169294A CY 169294 A CY169294 A CY 169294A CY 1692 A CY1692 A CY 1692A
- Authority
- CY
- Cyprus
- Prior art keywords
- treatments
- cognitive disorders
- ketone derivatives
- ketone
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868630075A GB8630075D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB878726424A GB8726424D0 (en) | 1987-11-11 | 1987-11-11 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1692A true CY1692A (en) | 1994-01-14 |
Family
ID=26291706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY169294A CY1692A (en) | 1986-12-17 | 1994-01-14 | Use of ketone derivatives in the treatments of cognitive disorders |
Country Status (15)
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5190954A (en) * | 1986-12-17 | 1993-03-02 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
US5200414A (en) * | 1986-12-17 | 1993-04-06 | Glaxo Group Limited | Methods for the treatment of cognitive disorders |
GB8805269D0 (en) * | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
US5229407A (en) * | 1988-09-01 | 1993-07-20 | Glaxo Group Limited | Medicaments |
GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
GB8914804D0 (en) * | 1989-06-28 | 1989-08-16 | Glaxo Group Ltd | Process |
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
EP0591434A4 (en) * | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
WO1993000075A1 (en) * | 1991-06-26 | 1993-01-07 | Sepracor, Inc. | Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
CA2157671A1 (en) * | 1993-03-08 | 1994-09-15 | Kiyotaka Katsuta | Medicament for treating or preventing cerebrovascular diseases |
ZA989365B (en) * | 1997-10-15 | 1999-04-15 | Boehringer Mannheim Pharm Corp | Preparation for treating alzheimer's disease |
DE60016892T2 (de) * | 1999-01-07 | 2005-12-15 | P.N. Gerolymatos S.A., Kryoneri | Verwendung von phanquinon zur behandlung und vorbeugung von gedächtnisschwund |
AU779696B2 (en) * | 1999-03-01 | 2005-02-10 | Sepracor, Inc. | Methods for treating apnea and apnea disorders using optically pure R(+)ondansetron |
US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
GB0701970D0 (en) | 2007-02-01 | 2007-03-14 | Wilson Stuart | Treatment of protein aggregation diseases |
US20100298397A1 (en) * | 2009-05-19 | 2010-11-25 | Singh Nikhilesh N | Method of treatment of obsessive compulsive disorder with ondansetron |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
DE3445377A1 (de) * | 1983-12-23 | 1985-07-04 | Sandoz-Patent-GmbH, 7850 Lörrach | Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen |
BE901576A (fr) * | 1984-01-25 | 1985-07-25 | Glaxo Group Ltd | Composes heterocycliques. |
EP0191562B1 (en) * | 1985-01-23 | 1991-07-10 | Glaxo Group Limited | Tetrahydrocarbazolone derivatives |
US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
EP0405617A3 (en) * | 1985-03-14 | 1992-11-25 | Beecham Group P.L.C. | Medicaments for the treatment of anxiety |
US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
-
1987
- 1987-12-16 JP JP62318456A patent/JP2608078B2/ja not_active Expired - Lifetime
- 1987-12-16 PH PH36242A patent/PH25025A/en unknown
- 1987-12-16 IL IL84845A patent/IL84845A0/xx not_active IP Right Cessation
- 1987-12-16 ES ES87311078T patent/ES2052585T3/es not_active Expired - Lifetime
- 1987-12-16 DK DK662687A patent/DK662687A/da not_active Application Discontinuation
- 1987-12-16 NZ NZ222950A patent/NZ222950A/en unknown
- 1987-12-16 AU AU82614/87A patent/AU618520B2/en not_active Ceased
- 1987-12-16 US US07/133,884 patent/US4845115A/en not_active Expired - Lifetime
- 1987-12-16 DE DE8787311078T patent/DE3782028T2/de not_active Expired - Lifetime
- 1987-12-16 EP EP87311078A patent/EP0275668B1/en not_active Expired - Lifetime
- 1987-12-16 IE IE341487A patent/IE60991B1/en not_active IP Right Cessation
- 1987-12-17 KR KR1019870014391A patent/KR950013450B1/ko not_active IP Right Cessation
-
1992
- 1992-11-16 GR GR920402595T patent/GR3006255T3/el unknown
-
1993
- 1993-04-15 HK HK366/93A patent/HK36693A/xx not_active IP Right Cessation
-
1994
- 1994-01-14 CY CY169294A patent/CY1692A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NZ222950A (en) | 1997-06-24 |
KR950013450B1 (ko) | 1995-11-08 |
ES2052585T3 (es) | 1994-07-16 |
AU8261487A (en) | 1988-06-23 |
EP0275668B1 (en) | 1992-09-30 |
JP2608078B2 (ja) | 1997-05-07 |
IE60991B1 (en) | 1994-09-07 |
DK662687D0 (da) | 1987-12-16 |
DE3782028D1 (de) | 1992-11-05 |
GR3006255T3 (US06566495-20030520-M00011.png) | 1993-06-21 |
EP0275668A2 (en) | 1988-07-27 |
IE873414L (en) | 1988-06-17 |
PH25025A (en) | 1991-01-28 |
US4845115A (en) | 1989-07-04 |
AU618520B2 (en) | 1992-01-02 |
HK36693A (en) | 1993-04-23 |
JPS63253083A (ja) | 1988-10-20 |
KR880007074A (ko) | 1988-08-26 |
IL84845A0 (en) | 1988-06-30 |
EP0275668A3 (en) | 1989-10-11 |
DE3782028T2 (de) | 1993-02-18 |
DK662687A (da) | 1988-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8600822D0 (en) | Treatment of skin disorders | |
EP0204597A3 (en) | Use of alfuzosine in the treatment of urinary affections | |
EP0326034A3 (en) | Combination for the treatment of nervous cells and fibers illnesses and disorders | |
AU6896487A (en) | Hair treatment agent | |
CY1692A (en) | Use of ketone derivatives in the treatments of cognitive disorders | |
SG96694G (en) | Treatment of skin disorders | |
PL268262A1 (en) | Weedicidal specific and the method of manufacturing of new derivatives of 2-benzoylcyclohexandion-1,3 | |
PT84704A (en) | Thiolactam-n-acetic derivatives their production and use | |
AU624067B2 (en) | Preparation suitable for use in the treatment of enteric disorders | |
EP0255801A3 (en) | Anilinotriazines and their use | |
PL266143A1 (en) | Weedicidal specific and the method of manufacturing of new derivatives of 2-benzoylcyclohexene-2-ane-1 | |
PL266144A1 (en) | Weedicidal specific and the method of manufacturing of new derivatives of 3-amino-2-benzoylcyclohexene-2-ane-1 | |
EP0267404A3 (en) | Use of praziquantel for the topical treatment of helminthiasis in cats | |
GB2203645B (en) | Improvements in the treatment of hair | |
GB2176104B (en) | Compositions for treatment of the hair and scalp. | |
GB8912373D0 (en) | Medicament for various skin and ulcer disorders | |
AU4096789A (en) | The use of lactam derivatives in the treatment of cognitive disorders | |
EP0238357A3 (en) | 1,2,4-triazinone derivatives, their preparation and use | |
GB8715914D0 (en) | Treatment of cerabral disorders | |
PL266142A1 (en) | Weedicidal specific and the method of manufacturing of new derivatives of 2-phenylaceto-cyclohexanotrion-1,3,5 | |
ZA87873B (en) | Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders | |
EP0407016A3 (en) | Use of benzodioxinopyrrole derivatives in the treatment of anxiety | |
EP0267537A3 (en) | Process for the preparation of vinylglyoxal derivatives, vinylglyoxal derivatives and their use | |
SG4695G (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases | |
ZA893606B (en) | Use of diazepinones for treating disorders of the microcirculation |